gemcitabine ready-to-use

	gemcitabine ready-to-use
Trade Name
Orphan Indication	Ovarian cancer
USA Market Approval	USA
USA Designation Date	2015-06-24 00:00:00
Sponsor	Sun Pharmaceutical Industries Ltd.;Acme Plaza, Andheri (East), Mumbai 400059;

Related Access Program

AstraZeneca – PSR Ovarian Cancer With a BRCA Mutation Tesaro, Inc. – Recurrent Ovarian Cancer AstraZeneca – Ovarian Cancer